FDA
approval
· 2025-02-21
FDA Approved: BOSENTAN — Supplemental Application (Actavis Pharma, Inc.)
Summary
FDA approved a supplemental application for Bosentan by Actavis Pharma, enabling a generic version of the pulmonary arterial hypertension medication to be manuf…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BOSENTAN (BOSENTAN)